Showing 5,171 results

Filters Content type: Editors' picks Country: United States
Bad science & bogus treatments

Pat Robertson, Medical Expert: 'The Towels Might Have AIDS'

Editor's pick
Poz
31 October 2014
HIV treatment

How Will Generic Drugs Affect HIV Treatment in the U.S.?

Editor's pick
The Body
31 October 2014
Combatting stigma

Positive Politics: Few elected officials are openly living with HIV/AIDS

Editor's pick
Poz
31 October 2014
Social & legal issues

Why Did AIDS Activists Go to Geneva to Cite U.S. HIV/AIDS Policies as a Form of Racial Discrimination?

Editor's pick
The Body
29 October 2014
PrEP

San Francisco to spend $300K improving access to PrEP

Editor's pick
San Francisco Examiner
29 October 2014
PrEP

Dr. Robert Grant, MD, MPH: The City of Love Could Lead the Way Toward Ending HIV Transmission

Editor's pick
Huffington Post
29 October 2014
Combatting stigma

New York's Ebola response should be informed by lessons learned fighting HIV. It isn't

Editor's pick
The Guardian
28 October 2014
Hepatitis C treatment

Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

Editor's pick
Poz magazine news
22 October 2014
History of HIV & AIDS

In Ebola fear, a familiar whiff of paranoia

Editor's pick
Washington Post
16 October 2014
Mental & emotional health problems

IDWeek 2014: Efavirenz Not Linked to Suicide in Analysis of Insurance Records

Editor's pick
HIVandHepatitis.com
16 October 2014
New & experimental hepatitis C treatment

Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

Editor's pick
Fair Pricing Coalition
15 October 2014
Pharmaceutical industry

If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Editor's pick
Wall Street Journal
15 October 2014
PrEP

The Welcome Side Effect of PrEP

Editor's pick
The Advocate
14 October 2014
Hepatitis C treatment

As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

Editor's pick
Forbes
10 October 2014
New & experimental hepatitis C treatment

U.S. Food and Drug Administration Approves Gilead’s Harvoni® (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C

Editor's pick
Gilead press release
10 October 2014
Retention & linkage to care

Less Than Half of HIV-Positive US Hispanics Are Getting Proper Care

Editor's pick
U.S. News & World Report
10 October 2014
HIV & criminal law

Charges Dropped in Nick Rhoades Iowa Criminalization Case

Editor's pick
Poz magazine news
9 October 2014
PrEP

The Pill Truvada Can Prevent HIV/AIDS, and for Some, That's a Problem

Editor's pick
Newsweek
8 October 2014
New & experimental hepatitis C treatment

In a surprise move, Bristol-Myers drops U.S. approval plans for hep C drug

Editor's pick
Fierce Biotech
7 October 2014
Hepatitis C treatment

CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill

Editor's pick
Forbes
7 October 2014
Access to healthcare

How Some State Medicaid Programs Limit Drugs to Only the Sickest Patients

Editor's pick
Governing.com
7 October 2014
Sex workers

Prostitute charged with not disclosing HIV status, again

Editor's pick
Fox News
7 October 2014
Side effects

Effective treatments available for HIV patients not eligible for efavirenz regimens

Editor's pick
Science Daily
7 October 2014
Hepatitis C treatment

New Hepatitis C Treatment Too Pricey For All Patients

Editor's pick
KJZZ Radio
7 October 2014